TSW
MRNA icon

Three Seasons Wealth’s Moderna MRNA Stock Holding History

Three Seasons Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$407K Buy
+8,016
New +$374K 0.16% 132
2024
Q3 		– Sell
-3,821
Closed -$454K – 111
2024
Q2 		$454K Buy
+3,821
New +$484K 0.25% 65

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Three Seasons Wealth's MRNA Position: Q1 2026 in Review

Three Seasons Wealth opened a new position in Moderna (MRNA) in Q1 2026: 8,016 shares worth $407K. The stake represents 0.16% of the portfolio and ranks #132 among its holdings. This is a return to the name: Three Seasons Wealth previously reported a position in MRNA as recently as Q2 2024.

Three Seasons Wealth first reported a position in MRNA in Q2 2024 and has held it in 2 quarters since. The position peaked at $454K in Q2 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Three Seasons Wealth held 8,016 shares of Moderna worth $407K as of Q1 2026.
  • Moderna was a new Three Seasons Wealth position in Q1 2026.
  • Moderna made up 0.16% of Three Seasons Wealth's portfolio in Q1 2026, its #132 holding.
  • Three Seasons Wealth first reported a position in Moderna in Q2 2024 and has held it in 2 quarters since.
  • Three Seasons Wealth's Moderna position peaked at $454K in Q2 2024.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Three Seasons Wealth's 13F filing for Q1 2026, filed 5 May 2026.